Abouzid MR, Ali K, Elkhawas I, Elshafei SM. An overview of diabetes mellitus in Egypt and the significance of integrating preventive cardiology in diabetes management. Cureus. 2022. https://doi.org/10.7759/cureus.27066.

Article  PubMed  PubMed Central  Google Scholar 

Association AD. 2. Diagnosis and classification of diabetes: standards of care in diabetes—2024. Diabetes Care. 2024;47(Supplement_1):S20–42.

Google Scholar 

Sayed Ahmed HA, Fouad AM, Elotla SF, Joudeh AI, Mostafa M, Shah A, et al. Prevalence and associated factors of diabetes distress, depression and anxiety among primary care patients with type 2 diabetes during the COVID-19 pandemic in Egypt: a cross-sectional study. Front Psychiatry. 2022;13: 937973.

PubMed  PubMed Central  Google Scholar 

Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol. 2024;14:1265372.

Google Scholar 

Fadel AW, Nawar AE, Elahwal LM, Ghali AA, Ragab OA. Early detection of peripheral neuropathy in patients with diabetes mellitus type 2. Egypt J Neurol Psychiatry Neurosurg. 2024;60(1):4.

Google Scholar 

Reda S, Fawzy O, Sayed D, Mohamed G, Khidr EG. Inactive matrix gla protein in relation to renal and cardiac functions and cardiac valvular calcification among type 2 diabetes patients. Clin Med Insights Endocrinol Diabetes. 2023;16:11795514231203862.

PubMed  PubMed Central  Google Scholar 

Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6(3):456.

PubMed  PubMed Central  Google Scholar 

González P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24(11):9352.

PubMed  PubMed Central  Google Scholar 

Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab. 2002;3(2):175–87.

PubMed  Google Scholar 

Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813–23.

PubMed  Google Scholar 

Zembron-Lacny A, Dziubek W, Tylutka A, Wacka E, Morawin B, Bulinska K, et al. Assessment of serum neopterin as a biomarker in peripheral artery disease. Diagnostics. 2021;11(10):1911.

PubMed  PubMed Central  Google Scholar 

Tezcan D, Onmaz DE, Sivrikaya A, Hakbilen S, Körez MK, Gülcemal S, et al. Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever. Ir J Med Sci (1971-). 2023;192(4):2015–22.

Google Scholar 

Eichwald T, da Silva LdB, Staats Pires AC, Niero L, Schnorrenberger E, Filho CC, et al. Tetrahydrobiopterin: beyond its traditional role as a cofactor. Antioxidants. 2023;12(5):1037.

PubMed  PubMed Central  Google Scholar 

Nechita V-I, Hajjar NA, Drugan C, Cătană C-S, Moiş E, Nechita M-A, et al. Chitotriosidase and neopterin as potential biomarkers for the evaluation of complicated cholecystitis—a pilot study. J Clin Med. 2023;12(4):1641.

PubMed  PubMed Central  Google Scholar 

Ghafouri B, Thordeman K, Hadjikani R, Bay Nord A, Gerdle B, Bäckryd E. An investigation of metabolome in blood in patients with chronic peripheral, posttraumatic/postsurgical neuropathic pain. Sci Rep. 2022;12(1):21714.

PubMed  PubMed Central  Google Scholar 

Yan J, Kothur K, Mohammad S, Chung J, Patel S, Jones HF, et al. CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation. EBioMedicine. 2023. https://doi.org/10.1016/j.ebiom.2023.104589.

Article  PubMed  PubMed Central  Google Scholar 

Abraham A, Barnett C, Katzberg HD, Lovblom LE, Perkins BA, Bril V. Toronto clinical neuropathy score is valid for a wide spectrum of polyneuropathies. Eur J Neurol. 2018;25(3):484–90.

PubMed  Google Scholar 

Hewedi KMA, Monzer MA, Sobh KM, Aboelmakarem MAM, Mohammady AA, Hasan MM, et al. Clinical and neurophysiological correlation in axonal and demyelinating polyneuropathy. Bull Natl Res Centre. 2020;44:1–6.

Google Scholar 

Elbarbary NS, Ismail EAR, El-Hilaly RA, Ahmed FS. Role of neopterin as a biochemical marker for peripheral neuropathy in pediatric patients with type 1 diabetes: relation to nerve conduction studies. Int Immunopharmacol. 2018;59:68–75.

PubMed  Google Scholar 

Cutaș A, Drugan C, Roman G, Rusu A, Cătană CS, Achimaș-Cadariu A, et al. Evaluation of chitotriosidase and neopterin as biomarkers of microvascular complications in patients with type 1 diabetes mellitus. Diagnostics. 2021;11(2):263.

PubMed  PubMed Central  Google Scholar 

Gürcü S, Girgin G, Yorulmaz G, Kılıçarslan B, Efe B, Baydar T. Neopterin and biopterin levels and tryptophan degradation in patients with diabetes. Sci Rep. 2020;10(1):17025.

PubMed  PubMed Central  Google Scholar 

Salem IA, Abdulsattar SA, Alrubaye HF. Evaluation of neopterin as a neuroinflammatory marker for peripheral neuropathy in type 2 diabetic patients. Al-Rafidain J Med Sci. 2023;5(1S):S183–8.

Google Scholar 

Melicharova K, Kusalova M, Smahelova A, Hyspler R, Solichova D, Melichar B. Urinary neopterin in patients with diabetes mellitus and foot ulcers. Pteridines. 2007;18(1):128–31.

Google Scholar 

Xue T, Zhang X, Xing Y, Liu S, Zhang L, Wang X, et al. Advances about immunoinflammatory pathogenesis and treatment in diabetic peripheral neuropathy. Front Pharmacol. 2021;12: 748193.

PubMed  PubMed Central  Google Scholar 

Wan R-H, Yuan Y, Hao W, Zheng L-Y, Lu J. Relationship between serum neopterin level and peripheral arterial plaque in patients with type 2 diabetes. Diabetes Metabolic Syndrome Obesity. 2021:2871–8.

Chuang S-C, Boeing H, Vollset SE, Midttun Ø, Ueland PM, Bueno-de-Mesquita B, et al. Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study. Immun Ageing. 2016;13:1–11.

Google Scholar